Zydus Cadila: Latest News

All news where Zydus Cadila is mentioned

21.08.2021 / 16:13

Zydus covid-19 vaccine to be launched by September

Zydus Cadila on Saturday indicated that it will launch its three-shot covid-19 vaccine ZyCov-D by September. The statement comes a day after the vaccine received emergency use authorisation (EUA) from the Drug Controller General of India (DCGI).

Zydus Cadila Sharvil Patel India covid-19 vaccine DNA

Zydus Cadila says clarity on price of its 3-dose Covid vaccine to come next week

Never miss a story! Stay connected and informed with Mint. Download our App Now!!

Zydus Cadila India information vaccine

Zydus Cadila's needle-free Covid-19 vaccine may get approval this week: Report

ANI.

Zydus Cadila India covid-19 vaccine DNA

Zydus Cadila gets DCGI nod to initiate Phase-3 clinical trials for covid-19 vaccine

NEW DELHI : Drug firm Zydus Cadila on Sunday said it has received DCGI approval to initiate Phase III clinical trials of its COVID-19 vaccine ZyCoV-D.The company will now be initiating Phase III clinical trial in around 30,000 volunteers, Zydus Cadila said in a statement.ZyCoV-D was found to be safe, well-tolerated and immunogenic in phase I and II clinical trials, it added.The phase II study of ZyCoV-D had been conducted in over 1,000 healthy adult volunteers as part of the adaptive Phase I/II dose-escalation, multi-centric, randomised, double-blind placebo-controlled study, the drug firm said.The trial has reviewed by an independent data safety monitoring board (DSMB) and reports were submitted to the Central Drugs Standard Control

Zydus Cadila city New Delhi covid-19 vaccine Volunteers

₹3K-5K crore to give all Indians Covid vaccine: Zydus Cadila chairman

COVID-19 vaccine, Zydus Cadila Chairman Pankaj R Patel said India would need to invest between ₹3,000-5,000 crore to create additional facilities for making a huge number of vaccines required for the Indian population. He also said that the vaccine alone is not the solution to the COVID-19 problem.

Zydus Cadila India covid-19 pandemic vaccine mask

Over 7 lakh covid patients in India cured so far, 40,000 new cases in 24 hours

coronavirus vaccine candidate Covaxin.Pharma major Zydus Cadila had also last week started clinical trials of its COVID-19 vaccine candidate with the first human dosing.Vaccine major Serum Institute of India, which is working on the AstraZeneca Oxford vaccine, plans to start human trials in India in August 2020.Click here to read the Mint ePaperLivemint.com is now on Telegram.

Zydus Cadila India covid-19 vaccine patient Coronavirus

Zydus gets Mexican regulator nod for Desidustat in test management of COVID-19

AHMEDABAD : Pharmaceutical major Zydus Cadila said on Monday it has got approval from Mexico's Federal Commission for the Protection against Sanitary Risk (COFEPRIS) for its one of its lead research candidate Desidustat to be tested in the management of COVID-19.The clinical and regulatory development of Desidustat in COVID-19 is being executed in Mexico by Avant Sante Research Centre, a leading contract research organisation headquartered in Monterrey."The company will be conducting a phase 2b, multi-centre, open-label, randomised, comparator-controlled study to evaluate the efficacy and safety of Desidustat tablet for the management of Covid-19 patients," said Zydus in a statement.As a part of the study, 100 mg tablets of Desidustat will

Zydus Cadila city Santé Mexico city Ahmedabad city Sanitary covid-19 recommendations testing

India's Zydus Cadila signs pact with Gilead to make remdesivir

BENGALURU : Indian drugmaker Zydus Cadila said on Friday it signed a non-exclusive agreement with Gilead Sciences Inc to manufacture and market antiviral drug remdesivir, the first treatment to show improvement in COVID-19 trials. Click here to read the Mint ePaperLivemint.com is now on Telegram.

Zydus Cadila India covid-19

Zydus explores biologicals route to treat COVID-19 with long-acting Interferon alpha-2b

Interferon alpha-2b has been used in the treatment of COVID-19 in China and Cuba and is a part of treatment guidelines of the Chinese government

Zydus Cadila China state Texas Cuba county Branch county Galveston city Ahmedabad virus covid-19 guidelines Government

Zydus Cadila gets tentative nod from USFDA for Parkinson's treatment capsule

The approval by the US Food and Drug Administration is for Carbidopa and Levodopa extended-release capsules in the strengths of 23.75 mg/95 mg, 36.25 mg/145 mg, 48.75 mg/195 mg, and 61.25 mg/245 mg, Cadila Healthcare said in a regulatory filing.

Zydus Cadila city New Delhi Usa India symptoms

United States	Cases: 46 252 513 Deaths: 750 423 Recovered: 0
India	Cases: 34 321 025 Deaths: 459 652 Recovered: 0
Brazil	Cases: 21 835 785 Deaths: 608 235 Recovered: 0
United Kingdom	Cases: 9 215 683 Deaths: 141 607 Recovered: 0
Russia	Cases: 8 494 589 Deaths: 237 619 Recovered: 0